Silver Book Fact

As the prevalence and impact of Alzheimer’s disease grows, so does the cost to the nation. The direct and indirect cost of Alzheimer’s and other dementias amount to more than $148 billion annually, which is more than the annual sales of any retailer in the world excluding Wal-Mart.

Vernon, John, Robert Goldberg, Yashodhara Dash, and Guruprasaadh Muralimohan. Alzheimer’s Disease and Cost-effectiveness Analyses: Ensuring good value for money?. Working Paper — Pending Publication; 2007. http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=12477

Reference

Title
Alzheimer’s Disease and Cost-effectiveness Analyses: Ensuring good value for money?
Publisher
Working Paper — Pending Publication
Publication Date
2007
Authors
Vernon, John, Robert Goldberg, Yashodhara Dash, and Guruprasaadh Muralimohan
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • 1.26 million physician office visits in 2010 were attributable to Parkinson’s disease.  
  • On average, Medicare spends about 3 times more per beneficiary diagnosed with Alzheimer’s or other dementias, compared to someone who does not have dementia ($13,207 compared to $4,454).  
  • Medicare spending on beneficiaries diagnosed with dementias is projected to increase from $91 billion in 2005 to $160 billion by 2010, and $189 billion by 2015.  
  • Annual Direct and Non-medical Costs Per Parkinson’s Patient
     
  • Among nursing home residents in the U.S. with Alzheimer’s and other dementias, 51% relied on Medicaid to help pay for their nursing home care in 2000.